Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statement of Changes in Stockholders??? Equity

v3.8.0.1
Unaudited Condensed Consolidated Statement of Changes in Stockholders’ Equity - USD ($)
Series A Preferred Stock [Member]
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2016 1,020,000   7,112,143      
Beginning balance, amount at Dec. 31, 2016 $ 1,020 $ 7,112 $ 86,266,075 $ (80,716,617) $ 5,557,590
Consulting fees paid in stock - non-cash payment of accrued expenses, Shares     102,975      
Consulting fees paid in stock - non-cash payment of accrued expenses, Amount $ 103 121,617 121,720
Shares issued - registered offerings – net of offering costs, Shares     5,236,001      
Shares issued - registered offerings – net of offering costs, Amount     $ 5,236 6,021,828 6,027,064
Cashless exercise of stock warrants, Shares     286,584      
Cashless exercise of stock warrants, Amount     $ 287 (287)  
Stock-based compensation       1,193,306 1,193,306
Net loss         (7,104,897) (7,104,897)
Ending balance, shares at Dec. 31, 2017 1,020,000 12,737,703      
Ending balance, amount at Dec. 31, 2017 $ 1,020 $ 12,738 93,602,539 (87,821,514) 5,794,783
Shares issued - registered offerings – net of offering costs, Shares     10,693,535      
Shares issued - registered offerings – net of offering costs, Amount     $ 10,694 20,711,521 20,722,215
Cashless exercise of stock warrants, Shares     496,644      
Cashless exercise of stock warrants, Amount     $ 496 (496)    
Stock-based compensation       1,273,035   1,273,035
Issuance of Preferred stock, Shares   2,666,667        
Issuance of Preferred stock, Amount   $ 2,667 3,897,334   3,900,001
Net loss         (4,721,487) (4,721,487)
Ending balance, shares at Mar. 31, 2018 1,020,000 2,666,667 23,927,882      
Ending balance, amount at Mar. 31, 2018 $ 1,020 $ 2,667 $ 23,928 $ 119,483,933 $ (92,543,001) $ 26,968,547